Monoclonal antibodies

Hip

Senior Member
Messages
11,969
Likes
20,890
This looks like it could end up as a future therapy for chronic fatigue syndrome:

Monoclonal antibodies: short-term therapy for the long-term treatment of chronic viral infections?

From the 4th paragraph of the above link:

...under certain conditions, a very short course of treatment (a few days) with antiviral monoclonal antibodies can have an additional effect similar to that of a vaccine. After three weeks, and even though the injected monoclonal antibodies had disappeared, the researchers indeed detected a potent and long-lasting (more than a year) antiviral immune response...
 

glenp

"and this too shall pass"
Messages
776
Likes
17
Location
Vancouver Canada suburbs
Very interesting!! I have often wondered what triggered good days that I used to have. I wonder if it could be antibodies?
I hope they do something with this soon.

glen
 
Messages
18
Likes
0
Yes, RItuximab (Mabthera) is one of them and is used in trials by Norway scientists to treat CFS. Actually, they must have finished their latest trial, but I don't see the results are out yet.
 

redo

Senior Member
Messages
869
Likes
153
Quote: "After three weeks, and even though the injected monoclonal antibodies had disappeared, the researchers indeed detected a potent and long-lasting (more than a year) antiviral immune response (...)"

"In mice, a short and early course of therapeutic monoclonal antibodies targeting both the viruses and the cells infected by these viruses thus enables permanent recovery from a fatal chronic infection."

Rituximab is a monoclonal antibody. And in a small trial it has given a strong temporary symptom relief lasting for over a month in 3/3 patients.

Perhaps monoclonal antibodies work even better if the person have received or is receiving ARV at the same time. Just a though...
 

mojoey

Senior Member
Messages
1,213
Likes
68
One of the abstracts presented at the NIH conference talked about TSG101 as being a protein that was expressed on every cell infected with a retrovirus. It also discussed the possible therapy of using monoclonal antibodies that target TSG101.